ArticleOncotarget2017

Surrogate endpoint for overall survival in assessment of adjuvant therapies after curative treatment for hepatocellular carcinoma: a re-analysis of meta-analyses of individual patients' data.

Hong-Bo Huan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.